Table 2.
Summary: Effects of surfactants.
| surfactant | concentration (%) | MRSA (ATCC BAA-2856) | 3T3 cell | ||
|---|---|---|---|---|---|
| inhibition of biofilm formation | growth inhibiton | toxicity | toxicity | ||
| BZC | 0.0005 | + | + | − | ± |
| 0.005 | + | + | − | + | |
| 0.05 | + | + | − | + | |
| 0.5 | + | + | + | + | |
| SDS | 0.0005 | − | − | − | − |
| 0.005 | − | − | − | + | |
| 0.05 | + | + | − | + | |
| 0.5 | + | + | − | + | |
| CHAPS | 0.0005 | − | − | − | − |
| 0.005 | − | − | − | − | |
| 0.05 | − | − | − | − | |
| 0.5 | + | − | − | + | |
| PS80 | 0.0005 | − | − | − | − |
| 0.005 | − | − | − | − | |
| 0.05 | + | − | − | − | |
| 0.5 | + | − | − | ± | |
The bactericidal action and toxicity of different surfactants used is summarized. All effects were graded into three excluding “toxicity” in bacteria (total negative: −, positive: +) using CFU analysis. Toxicity (%-viability reduction) in 3T3 fibroblasts was as follows: 10% ≥: −, 11–50%: ±, 51% ≤: +.